logo

Tag : market study

List of Lab Manager Surveys

Lab Manager Magazine routinely publishes surveys, often multiple per month, which briefly assess scientists’ utilization and preferences with regards to a particular laboratory technology. These surveys basically amount to free market research. They don’t go terribly in-depth, but if you’re looking for some basic information (such as feature preferences) about a particular type of instrument, they are a wonderful resource. Here at BioBM we archive them for in-house use and have a bookshelf lined with the physical magazines, but we thought this would be a good resource to share with everyone. Since Lab Manager doesn’t have an easily sortable list, we created one for you here. Every Lab Manager product survey from January 2011 to today is included, and we’ll be coming back periodically to update the table.

This resource has moved. You can find it here: https://biobm.com/resources/list-of-lab-manager-surveys/

Life Sci Tools Market Outlook

There’s been a lot of negativity in the life science tools market recently, at least with regards to the economic outlook. European government austerity, a possible US sequester, and cooling Asian economies have given a lot of people a sense of unease (or downright fear) about sector growth. Over the past two months, however, there’s a bunch of data that says things probably aren’t going to be so bad after all.

Back in late February, a MarketsandMarkets study projected the life science and chemical instrumentation market to grow at a compound annual growth rate (CAGR) of 8.4% from 2011 to 2016. Morgan Stanley analyst Daniel Brennan then noted in early March that commercial sales of publicly traded life science instrument companies had been stronger than expected and is less vulnerable to the economy than many had feared. A DeciBio study released last week projected that the life science tools market will grow by about 4% per year over the next 5 years. Sure, 4% isn’t a great growth rate, but it’s certainly enough to sustain the industry. Last Thursday, Goldman Sachs analyst Isaac Ro said that company performance in the life science tools industry for the first quarter of 2012 “appears to have trended better than initially expected” and noted that academic spending trends have improved.

While I wouldn’t go so far as to say that we’re in the clear, and there are certainly still hurdles the industry faces moving forward, we can all breathe a collective sigh of relief. The life science tools market isn’t in nearly as bad of shape as many had feared.

"Looking for growth in a challenging economy? Turn to BioBM Consulting. Our life science business and marketing experts can help your company develop and execute strategies that create demand and drive revenues regardless of external factors. Contact BioBM for more information."